Katherine Borden
Katherine Borden
Dirección de correo verificada de - Página principal
Citado por
Citado por
Does this have a familiar RING?
AJ Saurin, KLB Borden, MN Boddy, PS Freemont
Trends in biochemical sciences 21 (6), 208-214, 1996
Mechanisms and insights into drug resistance in cancer
H Zahreddine, KLB Borden
Frontiers in pharmacology 4, 28, 2013
The RING finger domain: a recent example of a sequence—structure family
KLB Borden, PS Freemont
Current opinion in structural biology 6 (3), 395-401, 1996
RING domains: master builders of molecular scaffolds?
KLB Borden
Journal of molecular biology 295 (5), 1103-1112, 2000
Identification and preliminary characterization of a protein motif related to the zinc finger.
R Lovering, IM Hanson, KL Borden, S Martin, NJ O'Reilly, GI Evan, ...
Proceedings of the National Academy of Sciences 90 (6), 2112-2116, 1993
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML.
KL Borden, MN Boddy, J Lally, NJ O'reilly, S Martin, K Howe, E Solomon, ...
The EMBO journal 14 (7), 1532-1541, 1995
Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies
KLB Borden
Molecular and cellular biology 22 (15), 5259-5269, 2002
eIF4E is a central node of an RNA regulon that governs cellular proliferation
B Culjkovic, I Topisirovic, L Skrabanek, M Ruiz-Gutierrez, KLB Borden
The Journal of cell biology 175 (3), 415-426, 2006
RING fingers and B-boxes: zinc-binding protein-protein interaction domains
KLB Borden
Biochemistry and Cell Biology 76 (2-3), 351-358, 1998
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis, I Topisirovic, B Culjkovic, L Shao, KLB Borden
Proceedings of the National Academy of Sciences 101 (52), 18105-18110, 2004
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
S Assouline, B Culjkovic, E Cocolakis, C Rousseau, N Beslu, A Amri, ...
Blood 114 (2), 257-260, 2009
Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities
I Topisirovic, M Ruiz-Gutierrez, KLB Borden
Cancer research 64 (23), 8639-8642, 2004
Solution structure of the PHD domain from the KAP‐1 corepressor: structural determinants for PHD, RING and LIM zinc‐binding domains
AD Capili, DC Schultz, FJ RauscherIII, KLB Borden
The EMBO journal, 2001
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo
L Fontan, C Yang, V Kabaleeswaran, L Volpon, MJ Osborne, E Beltran, ...
Cancer cell 22 (6), 812-824, 2012
PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
N Cohen, M Sharma, A Kentsis, JM Perez, S Strudwick, KLB Borden
The EMBO journal, 2001
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis
I Topisirovic, ML Guzman, MJ McConnell, JD Licht, B Culjkovic, ...
Molecular and cellular biology, 2003
eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′ UTR
B Culjkovic, I Topisirovic, L Skrabanek, M Ruiz-Gutierrez, KLB Borden
The Journal of cell biology 169 (2), 245-256, 2005
In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions
A Melnick, KF Ahmad, S Arai, A Polinger, H Ball, KL Borden, GW Carlile, ...
Molecular and Cellular Biology 20 (17), 6550-6567, 2000
The Mdm2 RING domain C‐terminus is required for supramolecular assembly and ubiquitin ligase activity
MV Poyurovsky, C Priest, A Kentsis, KLB Borden, ZQ Pan, N Pavletich, ...
The EMBO journal 26 (1), 90-101, 2007
Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E
B Culjkovic, I Topisirovic, KLB Borden
Cell cycle 6 (1), 65-69, 2007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20